The impact of COVID-19 on stroke care: An international and local perspective

Start Date: 04/06/2020
Start Time: 7:00 PM AEST
Duration: 60 minutes


The Australasian Stroke Academy (ASA) and the Acute Stroke Nurses Education Network (ASNEN) have come together to invite you to participate in this important live webinar with Vice President of the European Stroke Organisation (ESO) Prof. Charlotte Cordonnier from Lille University Hospital, France and Chair of the Stroke Foundation Clinical Council, Prof. Bruce Campbell from the Royal Melbourne Hospital, VIC.

In this one hour webinar Prof. Cordonnier will share her experiences from a pandemic hotspot in France and present the results from the ESO survey ‘Impact of the Crisis on Stroke Care’.

Prof. Campbell will discuss how the pandemic has disrupted the stroke service model in Australia, what we have learned from this and discuss how we can plan for the future.

A/Prof Henry Ma, President of ASA and Brett Jones, ASNEN steering committee member will then facilitate a Q&A session, with your active participation.

Program details / Learning objectives:

  • Gain key insights and learnings from a European Pandemic ‘Hot Spot’
  • Practical aspects of dealing with stroke patients in the time of COVID
  • The transition back to ‘normal’ and preparing for the future


Professor Charlotte Cordonnier

Professor of Neurology, MD, PhD, FESO, FEAN

Charlotte Cordonnier is a neurologist specialised in stroke medicine with a PhD thesis in Neurosciences. Appointed as Professor of Neurology at the Lille University (France) in 2012, she has been the head of the Stroke centre of the Lille university Hospital since 2015. Since 2018, she chairs the department of Neurology. She was trained in Lille by Prof. Didier Leys. Her research interests are intracerebral haemorrhages (including microbleeds) both in the setting of stroke and dementia, acute management of stroke, and stroke specificities in women. She is the director of the Lille Haemorrhagic Stroke research program inside the INSERM U1172. She was vice-president of the European Stroke Organisation (2016 -2020) and is currently a member of the scientific committee of the European Academy of Neurology. Since April 2020, she serves as Associate Editor for the Stroke journal

Professor Bruce Campbell


Professor Bruce Campbell is a consultant neurologist and Head of Stroke, Royal Melbourne Hospital. He is a professorial fellow in the Melbourne Brain Centre at RMH, Department of Medicine, University of Melbourne, an honorary professorial fellow at The Florey Institute of Neuroscience and Mental Health and a fellow of the Australian Academy of Health and Medical Science. His research interests are focused on the imaging and treatment of acute stroke and he was co-principal investigator and medical co-ordinator of the EXTEND-IA and EXTEND-IA TNK multi-centre randomised trials published in the New England Journal of Medicine in 2015 and 2018. He is Chair of Clinical Council and a director of the Stroke Foundation and co-chairs the Australian stroke “living” guidelines working party. He has been an inaugural member of the Victorian stroke telemedicine project and chairs the Victorian Statewide Stroke Reperfusion Therapy Committee. He co-chairs the World Stroke Organisation Young Stroke Professionals Committee and is the co-ordinator of the National Brainschool training program for neurologists in training.

Professor Henry Ma


Professor Henry Ma is the Director of the Neurology Department of Monash Health and adjunct clinical Professor of Monash University. He is the President of Australasia Stroke Academy. His research interests include clinical trials, neuroimaging and acute stroke treatment.

Brett Jones

Stroke Nurse Practitioner

Brett Jones is a Stroke Nurse Practitioner currently employed in the Canberra Hospital. Brett has worked in stroke care across a number of roles over the last 16 years and more recently assisted in the establishment of Canberra Hospital’s 24/7 ECR service.

If you're already registered for the webcast, click below:

First Name
Last Name
APHRA Number
Email Address
Practice Postcode
Practice location
Yes I have read and accepted the privacy statement
Boehringer Ingelheim Privacy Statement:
Boehringer Ingelheim Pty Limited. ABN 52 000 452 308. 78 Waterloo Road, North Ryde NSW 2113. If you need to report an Adverse event for Boehringer Ingelheim products please contact our Medical information on (02 8875 8800) or 1800 226 315. Boehringer Ingelheim Pty Limited and Boehringer Ingelheim Animal Health Australia Pty Ltd (collectively referred to as “BI”) are bound by the Australian Privacy Principles (“APPs”) and adhere to these Principles. The personal information BI collects from you when you access and use the website will be used for the purpose of enabling you to access and use the website and to provide you with other BI educational and promotional communications (“this purpose”). If you do not provide all or some of the requested personal information to us, we may not be able to provide you with access to the website and we may not be able to keep you up-to-date with BI educational and promotional information. We may disclose your personal information to third party contractors who we engage to assist us with this purpose. We keep your personal information in secure databases that may be hosted on servers that are located outside of Australia (such as in the USA, Japan, Singapore and Germany), in which case we may disclose your personal information to those overseas hosting providers for that purpose only. We may also disclose your personal information to any entity within the worldwide group of Boehringer Ingelheim companies some of which are located outside of Australia including but not limited to New Zealand, Germany and the USA. Our Privacy Policy (at contains information about how you can access and request the correction of your personal information, how you can make a complaint about a breach of the APPs and how we will deal with your complaint. You can contact BI or our Privacy Officer by email at or on +(61)(2) 8875 8800.